Aciclovir
This medicine should always be used exactly as described in this package leaflet or as directed by a doctor, pharmacist, or nurse.
Heviran Comfort cream for topical use contains the active substance acyclovir, which has antiviral properties and is effective against the herpes simplex virus.
Heviran Comfort cream is indicated for the local treatment of recurrent herpes labialis (cold sores) and facial herpes caused by the herpes simplex virus.
If there is no improvement or the patient feels worse after 10 days, they should contact their doctor.
Before starting treatment with Heviran Comfort, the patient should discuss it with their doctor, pharmacist, or nurse if:
Heviran Comfort should not be used without consulting a doctor if:
Do not use the cream:
Heviran Comfort should only be used for herpes lesions on the lips and face.
If the herpes lesions have not cleared up or have worsened after 10 days, the patient should consult their doctor.
Contact with the eyes should be avoided. If the medicine gets into the eyes, they should be rinsed thoroughly with warm water. If in doubt, the patient should consult their doctor.
Hands should be washed before and after using the medicine to prevent the spread of infection to other areas of the skin. During treatment, the patient should not scratch the blisters or crusts or touch them with a towel.
To minimize the risk of spreading the infection to others, they should not be allowed to touch the herpes lesions, share towels, etc.
This medicine should not be used in children under 6 years of age.
The patient should inform their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
Interactions between Heviran Comfort and other medicines are not known.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor before using this medicine.
Heviran Comfort has no or negligible influence on the ability to drive and use machines.
Each gram of cream contains 400 mg of propylene glycol. Propylene glycol may cause skin irritation.
The medicine contains cetearyl alcohol, which may cause local skin reactions (e.g., contact dermatitis).
The medicine contains 7.5 mg of sodium lauryl sulfate per gram of cream.
Sodium lauryl sulfate may cause local skin irritation (such as stinging or burning) or exacerbate skin reactions caused by other medicines used on the same area of skin.
This medicine should always be used exactly as described in the package leaflet or as directed by a doctor, pharmacist, or nurse. If in doubt, the patient should consult their doctor, pharmacist, or nurse.
The medicine should be applied 5 times a day to the affected areas of skin at approximately 4-hour intervals, with a night-time break. The medicine works best if treatment is started as soon as possible after the first symptoms of herpes appear, such as tingling, itching, or redness. Treatment can also be started later, when blisters or crusts have formed.
In children from 6 to 12 years of age, the use of the medicine should be supervised by a doctor.
Duration of treatment
Treatment should be continued for at least 4 days.
If the skin lesions have not healed, treatment can be extended up to 10 days. If the lesions have not cleared up after 10 days of treatment, the patient should consult their doctor.
Method of administration
Topical application.
Apply the medicine directly to the herpes lesions on the lips and face without touching them with your hands. Avoid scratching the lesions or touching them with a towel.
This medicine is for use by one person only. After opening the package, it should only be used by one patient.
To prevent the spread of infection, hands should be washed before and after applying the medicine, and the patient should avoid unnecessary rubbing of the lesions or touching them with a towel.
If the patient feels that the effect of the medicine is too strong or too weak, they should consult their doctor.
In case of accidental ingestion of the cream, the patient should contact their doctor or pharmacist.
A double dose should not be used to make up for a missed dose. If a dose is missed, the patient should apply the cream as soon as they remember and continue treatment as before.
If the patient has any further doubts about using this medicine, they should consult their doctor, pharmacist, or nurse.
Like all medicines, Heviran Comfort can cause side effects, although not everybody gets them.
The following side effects may occur:
Uncommon(affecting up to 1 in 100 people)
Rare(affecting up to 1 in 1,000 people)
Very rare(affecting less than 1 in 10,000 people)
If the patient experiences any side effects, including those not listed in this package leaflet, they should inform their doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Drug Safety, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the package. The expiry date refers to the last day of the month.
Do not store above 25°C.
The shelf life after opening the tube is 1 year.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines they no longer need. This will help protect the environment.
Heviran Comfort is a white, smooth cream with a characteristic odor.
Heviran Comfort cream is packaged in aluminum tubes with an internal membrane, coated with epoxy-phenolic lacquer, with an HDPE cap and a piercer, in a cardboard box.
Package sizes: 2 g, 5 g, or 10 g.
Not all package sizes may be marketed.
Zakłady Farmaceutyczne POLPHARMA S.A.
ul. Pelplińska 19, 83-200 Starogard Gdański
phone: +48 22 364 61 01
Medinfar Manufacturing, S.A.
Parque Industrial Armando Martins Tavares, Rua Outeiro da Armada, 5
Condeixa-a-Nova 3150-194 Sebal, Portugal
Date of last revision of the package leaflet:November 2023
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.